Literature DB >> 25345995

Hypogonadal symptoms in young men are associated with a serum total testosterone threshold of 400 ng/dL.

Jason M Scovell1, Ranjith Ramasamy1, Nathan Wilken1, Jason R Kovac1, Larry I Lipshultz1.   

Abstract

OBJECTIVE: To investigate the association between hypogonadal symptoms and serum total testosterone (TT) levels in young men (aged <40 years), in an attempt to determine whether there exists a clear-cut discriminatory threshold of TT below which hypogonadal symptoms become more prevalent. PATIENTS AND METHODS: We retrospectively reviewed the charts of 352 men who presented to an outpatient Men's Health Clinic with chief complaint of 'low testosterone'. Sexual, psychological and physical symptoms were evaluated using the Androgen deficiency in Aging Male (ADAM) questionnaire. Serum levels of TT were collected on the same day that men completed their ADAM questionnaires. We subsequently performed univariate (t-test, chi-square) and multivariate analyses (ordinal logistic regression) to evaluate factors that predicted a low TT level.
RESULTS: The probability of hypogonadal symptoms increased at a serum TT level of 400 ng/dL. A cluster of symptoms: two psychological ('decreased energy', 'sadness'), and three physical ('decreased strength and endurance', 'decreased ability to play sports', and 'deterioration in work performance') were most strongly associated with serum TT levels of <400 ng/dL. On multivariable analysis, only 'lack of energy' predicted a TT level of <400 ng/dL.
CONCLUSIONS: Hypogonadal symptoms in men aged <40 years can be associated with a TT level of <400 ng/dL. Of the hypogonadal symptoms evaluated with the ADAM questionnaire, 'lack of energy' appears to be the most important symptom that predicts a TT level of <400 ng/dL.
© 2014 The Authors BJU International © 2014 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ADAM; ageing male; androgen deficiency; erectile dysfunction; libido

Mesh:

Substances:

Year:  2015        PMID: 25345995     DOI: 10.1111/bju.12970

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  7 in total

Review 1.  Diagnosis and treatment of infertility-related male hormonal dysfunction.

Authors:  Martin Kathrins; Craig Niederberger
Journal:  Nat Rev Urol       Date:  2016-04-19       Impact factor: 14.432

Review 2.  Age-related testosterone decline is due to waning of both testicular and hypothalamic-pituitary function.

Authors:  Ron Golan; Jason M Scovell; Ranjith Ramasamy
Journal:  Aging Male       Date:  2015-06-15       Impact factor: 5.892

3.  Efficacy and Safety of Human Chorionic Gonadotropin Monotherapy for Men With Hypogonadal Symptoms and Normal Testosterone.

Authors:  Isaac Zucker; Quinn Rainer; Raghav K Pai; Ranjith Ramasamy; Thomas A Masterson
Journal:  Cureus       Date:  2022-05-31

Review 4.  The practical management of testosterone deficiency in men.

Authors:  Antonio Aversa; Abraham Morgentaler
Journal:  Nat Rev Urol       Date:  2015-10-13       Impact factor: 14.432

5.  Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.

Authors:  Bruno Lunenfeld; George Mskhalaya; Michael Zitzmann; Stefan Arver; Svetlana Kalinchenko; Yuliya Tishova; Abraham Morgentaler
Journal:  Aging Male       Date:  2015-02-06       Impact factor: 5.892

Review 6.  Testosterone therapy in the new era of Food and Drug Administration oversight.

Authors:  Bethany Desroches; Taylor P Kohn; Charles Welliver; Alexander W Pastuszak
Journal:  Transl Androl Urol       Date:  2016-04

Review 7.  Low Testosterone in Adolescents & Young Adults.

Authors:  Jordan Cohen; Daniel E Nassau; Premal Patel; Ranjith Ramasamy
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-10       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.